Literature DB >> 17975226

Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking.

Margherita Neri1, Claudio Maderna, Chiara Cavazzin, Vivien Deidda-Vigoriti, Letterio S Politi, Giuseppe Scotti, Pasquina Marzola, Andrea Sbarbati, Angelo L Vescovi, Angela Gritti.   

Abstract

Recent studies have raised appealing possibilities of replacing damaged or lost neural cells by transplanting in vitro-expanded neural precursor cells (NPCs) and/or their progeny. Magnetic resonance (MR) tracking of superparamagnetic iron oxide (SPIO)-labeled cells is a noninvasive technique to track transplanted cells in longitudinal studies on living animals. Murine NPCs and human mesenchymal or hematopoietic stem cells can be efficiently labeled by SPIOs. However, the validation of SPIO-based protocols to label human neural precursor cells (hNPCs) has not been extensively addressed. Here, we report the development and validation of optimized protocols using two SPIOs (Sinerem and Endorem) to label human hNPCs that display bona fide stem cell features in vitro. A careful titration of both SPIOs was required to set the conditions resulting in efficient cell labeling without impairment of cell survival, proliferation, self-renewal, and multipotency. In vivo magnetic resonance imaging (MRI) combined with histology and confocal microscopy indicated that low numbers (5 x 10(3) to 1 x 10(4)) of viable SPIO-labeled hNPCs could be efficiently detected in the short term after transplantation in the adult murine brain and could be tracked for at least 1 month in longitudinal studies. By using this approach, we also clarified the impact of donor cell death to the MR signal. This study describes a simple protocol to label NPCs of human origin using SPIOs at optimized low dosages and demonstrates the feasibility of noninvasive imaging of labeled cells after transplantation in the brain; it also evidentiates potential limitations of the technique that have to be considered, particularly in the perspective of neural cell-based clinical applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975226     DOI: 10.1634/stemcells.2007-0251

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  66 in total

1.  Human skeletal muscle stem cell antiinflammatory activity ameliorates clinical outcome in amyotrophic lateral sclerosis models.

Authors:  Laura Canzi; Valeria Castellaneta; Stefania Navone; Sara Nava; Marta Dossena; Ileana Zucca; Tiziana Mennini; Paolo Bigini; Eugenio A Parati
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

2.  Ferritin enhances SPIO tracking of C6 rat glioma cells by MRI.

Authors:  Jiandong Wang; Jin Xie; Xiaojun Zhou; Zhen Cheng; Ning Gu; Gaojun Teng; Qiujue Hu; Feipeng Zhu; Shuanghui Chang; Fan Zhang; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

Review 3.  In vivo tracking of cellular therapeutics using magnetic resonance imaging.

Authors:  Christoper M Long; Jeff W M Bulte
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

Review 4.  Cell-based therapy in ischemic stroke.

Authors:  David C Hess; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

5.  Tracking induced pluripotent stem cells-derived neural stem cells in the central nervous system of rats and monkeys.

Authors:  Hailiang Tang; Hongying Sha; Huaping Sun; Xing Wu; Liqian Xie; Pu Wang; Chengshi Xu; Christian Larsen; Helen L Zhang; Ye Gong; Ying Mao; Xiancheng Chen; Liangfu Zhou; Xiaoyuan Feng; Jianhong Zhu
Journal:  Cell Reprogram       Date:  2013-09-10       Impact factor: 1.987

6.  Labelling of mammalian cells for visualisation by MRI.

Authors:  Monique R Bernsen; Amber D Moelker; Piotr A Wielopolski; Sandra T van Tiel; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2009-08-12       Impact factor: 5.315

Review 7.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

8.  Labeling protocols for in vivo tracking of human skeletal muscle cells (HSkMCs) by magnetic resonance and bioluminescence imaging.

Authors:  Ilaria V Libani; Giovanni Lucignani; Umberto Gianelli; Anna Degrassi; Micaela Russo; Silvano Bosari; Mario Clerici; Luisa Ottobrini
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

9.  Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform.

Authors:  Jonathan Riley; Thais Federici; John Park; Masatoshi Suzuki; Colin K Franz; Craig Tork; Jacalyn McHugh; Qingshan Teng; Clive Svendsen; Nicholas M Boulis
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

10.  Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.

Authors:  Mya S Thu; Joseph Najbauer; Stephen E Kendall; Ira Harutyunyan; Nicole Sangalang; Margarita Gutova; Marianne Z Metz; Elizabeth Garcia; Richard T Frank; Seung U Kim; Rex A Moats; Karen S Aboody
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.